Interval colon cancer in a Lynch syndrome patient under annual colonoscopic surveillance: a case for advanced imaging techniques?

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Oxentenko, Amy S ^a   Smyrk, Thomas C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Colorectal carcinoma, Surveillance; Lynch syndrome

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; PROTEIN MLH1;

ADULT; ARTICLE; CASE REPORT; COLON BIOPSY; COLON RESECTION; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; ENDOMETRIOSIS; FAMILY HISTORY; FEMALE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; HUMAN TISSUE; HYPOTHYROIDISM; HYSTERECTOMY; ILEORECTOSTOMY; IMMUNOHISTOCHEMISTRY; INTESTINE SURGERY; JEJUNUM TUMOR; MIGRAINE; MISSENSE MUTATION; SALPINGOOOPHORECTOMY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; COLECTOMY; COLONIC NEOPLASMS; COLONOSCOPY; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; EARLY DIAGNOSIS; FEMALE; HUMANS; ILEOSTOMY; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; TREATMENT OUTCOME;

EID: 84861337660     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-50     Document Type: Article

References (33)

1. Jass JR. Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term. World J Gastroenterol 2006, 12(31):4943-4950.
2. Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch PM, Cavalieri RJ, Boland CR. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993, 104(5):1535-1549.
3. Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 2006, 354(3):261-269. 10.1056/NEJMoa052627, 16421367.
4. Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, Lynch P, Burke W, Press N. Recommendations for the care of individuals with an inherited predisposition to lynch syndrome. JAMA: 2006, 296(12):1507-1517.
5. Boland CR. Speed kills. Clin Gastroenterol Hepatol 2011, 9(4):290-292. 10.1016/j.cgh.2010.12.023, 3085133, 21195793.
6. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. NEngl J Med 2003, 348(10):919-932.
7. Samowitz WS, Curtin K, Lin HH, Robertson MA, Schaffer D, Nichols M, Gruenthal K, Leppert MF, Slattery ML. The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology 2001, 121(4):830-838. 10.1053/gast.2001.27996, 11606497.
8. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Clendenning M, Sotamaa K, Prior T, Westman JA, et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 2008, 26(35):5783-5788. 10.1200/JCO.2008.17.5950, 2645108, 18809606.
9. Salovaara R, Loukola A, Kristo P, Kaariainen H, Ahtola H, Eskelinen M, Harkonen N, Julkunen R, Kangas E, Ojala S, et al. Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 2000, 18(11):2193-2200.
10. Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, Nagengast FM, Meijers-Heijboer EH, Bertario L, Varesco L, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996, 110(4):1020-1027. 10.1053/gast.1996.v110.pm8612988, 8612988.
11. Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, Peltomaki P, Mecklin JP, Jarvinen HJ. Cancer risk in mutation carriers of DNA-mismatch-repair genes. International J Cancer 1999, 81(2):214-218.
12. Quehenberger F, Vasen HF, van Houwelingen HC. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. Journal of medical genetics 2005, 42(6):491-496. 10.1136/jmg.2004.024299, 1736072, 15937084.
13. Stoffel E, Mukherjee B, Raymond VM, Tayob N, Kastrinos F, Sparr J, Wang F, Bandipalliam P, Syngal S, Gruber SB. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology 2009, 137(5):1621-1627. 10.1053/j.gastro.2009.07.039, 2767441, 19622357.
14. Diergaarde B, Braam H, Vasen HF, Nagengast FM, van Muijen GN, Kok FJ, Kampman E. Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer. Clin Gastroenterol Hepatol 2007, 5(6):736-742. 10.1016/j.cgh.2007.02.019, 17544999.
15. Lindgren G, Liljegren A, Jaramillo E, Rubio C, Lindblom A. Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer. Gut 2002, 50(2):228-234. 10.1136/gut.50.2.228, 1773092, 11788565.
16. Mecklin JP, Aarnio M, Laara E, Kairaluoma MV, Pylvanainen K, Peltomaki P, Aaltonen LA, Jarvinen HJ. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome. Gastroenterology 2007, 133(4):1093-1098. 10.1053/j.gastro.2007.08.019, 17919485.
17. Pendergrass CJ, Edelstein DL, Hylind LM, Phillips BT, Iacobuzio-Donahue C, Romans K, Griffin CA, Cruz-Correa M, Tersmette AC, Offerhaus GJ, et al. Occurrence of colorectal adenomas in younger adults: an epidemiologic necropsy study. Clin Gastroenterol Hepatol 2008, 6(9):1011-1015. 10.1016/j.cgh.2008.03.022, 2629450, 18558514.
18. Jarvinen HJ, Aarnio M, Mustonenn H, Aktan-Collan K, Aaltonen LA, Peltomaki P, De La Chapelle A, Mecklin J-P. Controlled 15-year trial on screening for colorectal cancer in families with Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 2000, 118:829-834. 10.1016/S0016-5085(00)70168-5, 10784581.
19. de Jong AE, Hendriks YM, Kleibeuker JH, de Boer SY, Cats A, Griffioen G, Nagengast FM, Nelis FG, Rookus MA, Vasen HF. Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 2006, 130(3):665-671. 10.1053/j.gastro.2005.11.032, 16530507.
20. Halvarsson B, Lindblom A, Johansson L, Lagerstedt K, Nilbert M. Loss of mismatch repair protein immunostaining in colorectal adenomas from patients with hereditary nonpolyposis colorectal cancer. Modern pathol 2005, 18(8):1095-1101.
21. Iino H, Simms L, Young J, Arnold J, Winship IM, Webb SI, Furlong KL, Leggett B, Jass JR. DNA microsatellite instability and mismatch repair protein loss in adenomas presenting in hereditary non-polyposis colorectal cancer. Gut 2000, 47(1):37-42. 10.1136/gut.47.1.37, 1727981, 10861262.
22. Lynch H, Smyrk T, Jass JR, Nan TS. Hereditary nonpolyposis colorectal cancer and colonic adenomas: Aggressive adenomas?. Sem Surgical Oncol 1995, 11:406-410.
23. Ahlquist DA. Aggressive polyps in hereditary nonpolyposis colorectal cancer: targets for screening. Gastroenterology 1995, 108(5):1590-1592. 10.1016/0016-5085(95)90711-4, 7729653.
24. Jass JR, Stewart SM. Evolution of hereditary non-polyposis colorectal cancer. Gut 1992, 33(6):783-786. 10.1136/gut.33.6.783, 1379336, 1624160.
25. Edelstein DL, Axilbund J, Baxter M, Hylind LM, Romans K, Griffin CA, Cruz-Correa M, Giardiello FM. Rapid development of colorectal neoplasia in patients with Lynch syndrome. Clin Gastroenterol Hepatol 2011, 9(4):340-343. 10.1016/j.cgh.2010.10.033, 3073674, 21070872.
26. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, Woolf SH, Glick SN, Ganiats TG, Bond JH, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997, 112(2):594-642. 10.1053/gast.1997.v112.agast970594, 9024315.
27. Jarvinen HJ, Renkonen-Sinisalo L, Aktan-Collan K, Peltomaki P, Aaltonen LA, Mecklin JP. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol 2009, 27(28):4793-4797. 10.1200/JCO.2009.23.7784, 19720893.
28. Vasen HF, Abdirahman M, Brohet R, Langers AM, Kleibeuker JH, van Kouwen M, Koornstra JJ, Boot H, Cats A, Dekker E, et al. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. Gastroenterology 2010, 138(7):2300-2306. 10.1053/j.gastro.2010.02.053, 20206180.
29. Engel C, Rahner N, Schulmann K, Holinski-Feder E, Goecke TO, Schackert HK, Kloor M, Steinke V, Vogelsang H, Moslein G, et al. Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer. Clin Gastroenterol Hepatol 2010, 8(2):174-182. 10.1016/j.cgh.2009.10.003, 19835992.
30. Heresbach D, Barrioz T, Lapalus MG, Coumaros D, Bauret P, Potier P, Sautereau D, Boustiere C, Grimaud JC, Barthelemy C, et al. Miss rate for colorectal neoplastic polyps: a prospective multicenter study of back-to-back video colonoscopies. Endoscopy 2008, 40(4):284-290. 10.1055/s-2007-995618, 18389446.
31. Stoffel EM, Turgeon DK, Stockwell DH, Zhao L, Normolle DP, Tuck MK, Bresalier RS, Marcon NE, Baron JA, Ruffin MT, et al. Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer). Cancer prev res 2008, 1(6):470-475.
32. Huneburg R, Lammert F, Rabe C, Rahner N, Kahl P, Buttner R, Propping P, Sauerbruch T, Lamberti C. Chromocolonoscopy detects more adenomas than white light colonoscopy or narrow band imaging colonoscopy in hereditary nonpolyposis colorectal cancer screening. Endoscopy 2009, 41(4):316-322. 10.1055/s-0028-1119628, 19340735.
33. Stoffel EM, Chittenden A. Genetic testing for hereditary colorectal cancer: challenges in identifying, counseling, and managing high-risk patients. Gastroenterology 2010, 139(5):1436-1441. 1441 e1431, 10.1053/j.gastro.2010.09.018, 20858494.